Blood centres across India that do not clear mandatory quality audits may soon be stopped from carrying out routine testing until they find out what went wrong and correct it, according to proposals submitted to the country's top drug-regulatory advisory body.

The proposal, submitted to the apex advisory body on drug regulation, is aimed at centres that fail the mandatory quality audits they are required to undergo. Under the plan, such centres would be barred from conducting routine testing until they identify the cause of the failure and fix it.

The move, as set out in the proposals, links the ability to carry out routine testing to the outcome of these mandatory audits. No further details were immediately available.

The proposal is currently before the top drug-regulatory advisory body, and no decision has been announced.